Montrouge, France

Pierre Walrafen

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Pierre Walrafen: Innovator in Genetic Analysis

Introduction

Pierre Walrafen is a notable inventor based in Montrouge, France. He has made significant contributions to the field of genetic analysis, holding a total of 4 patents. His work focuses on methods for analyzing nucleic acid sequences, which have important implications for diagnosing genetic disorders.

Latest Patents

One of Walrafen's latest patents is a method for analyzing D4Z4 tandem repeat arrays of nucleic acid. This invention relates to a technique for analyzing in vitro D4Z4 tandem repeat arrays found on chromosomes, particularly Human chromosomes 4 and 10. The method is designed to determine the number of D4Z4 repeat units in these arrays. It utilizes molecular combing and specially designed nucleic acid probes. Another significant patent involves identifying genomic rearrangements in biological samples. This method enhances the detection and visualization of polynucleotide sequences, which is crucial for assessing various diseases, including cancer.

Career Highlights

Throughout his career, Walrafen has worked with prominent organizations such as Genomic Vision and the Institut Pasteur. His experience in these institutions has allowed him to develop innovative techniques that advance the field of genetic research.

Collaborations

Walrafen has collaborated with notable colleagues, including Aaron Bensimon and Ronald Lebofsky. These partnerships have contributed to the development of his groundbreaking methods and technologies.

Conclusion

Pierre Walrafen is a distinguished inventor whose work in genetic analysis has led to important advancements in the field. His patents reflect a commitment to improving diagnostic methods for genetic disorders, showcasing his impact on medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…